Cargando…
Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
World Allergy Organization
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406362/ http://dx.doi.org/10.1186/1939-4551-8-S1-A20 |
| _version_ | 1782367753576906752 |
|---|---|
| author | Compalati, Enrico Rinciani, Antonio |
| author_facet | Compalati, Enrico Rinciani, Antonio |
| author_sort | Compalati, Enrico |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4406362 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | World Allergy Organization |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-44063622015-04-28 Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite Compalati, Enrico Rinciani, Antonio World Allergy Organ J Meeting Abstract World Allergy Organization 2015-04-08 /pmc/articles/PMC4406362/ http://dx.doi.org/10.1186/1939-4551-8-S1-A20 Text en Copyright © 2015 Compalati and Rinciani; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Meeting Abstract Compalati, Enrico Rinciani, Antonio Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| title | Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| title_full | Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| title_fullStr | Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| title_full_unstemmed | Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| title_short | Safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| title_sort | safety of injective immunotherapy with monomeric carbamylated allergoid given to pediatric patients with allergic rhinitis with/without asthma due to house dust mite |
| topic | Meeting Abstract |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4406362/ http://dx.doi.org/10.1186/1939-4551-8-S1-A20 |
| work_keys_str_mv | AT compalatienrico safetyofinjectiveimmunotherapywithmonomericcarbamylatedallergoidgiventopediatricpatientswithallergicrhinitiswithwithoutasthmaduetohousedustmite AT rincianiantonio safetyofinjectiveimmunotherapywithmonomericcarbamylatedallergoidgiventopediatricpatientswithallergicrhinitiswithwithoutasthmaduetohousedustmite |